Oncogenomics data can guide clinical treatment decisions, but often such data are neither
actionable nor predictive. Functional ex vivo drug testing contributes significant additional, …

Introduction Acquired cancer therapy resistance evolves under selection pressure of immune
surveillance and favors mechanisms that promote drug resistance through cell survival and …

Incidence, molecular presentation and outcome of acute myeloid leukaemia (AML) are
influenced by sex, but little attention has been directed at untangling sex‐related molecular and …

The success of tissue engineering depends on the rapid and efficient formation of a functional
blood vasculature. Adult blood vessels comprise endothelial cells and perivascular mural …

Aberrant pro-survival signaling is a hallmark of cancer cells, but the response to chemotherapy
is poorly understood. In this study, we investigate the initial signaling response to …

Innate drug sensitivity in healthy cells aids identification of lineage specific anti-cancer
therapies and reveals off-target effects. To characterize the diversity in drug responses in the …

We describe here a simple and efficient antibody titration approach for cell‐surface markers
and intracellular cell signaling targets for mass cytometry. The iterative approach builds …

The formation of new blood vessels by sprouting angiogenesis is tightly regulated by contextual
cues that affect angiogeneic growth factor signaling. Both constitutive activation and loss …

Recurrent somatic internal tandem duplications (ITD) in the FMS‐like tyrosine kinase 3 (FLT3)
gene characterise approximately one third of patients with acute myeloid leukaemia (AML)…

Axl is a member of the TAM (Tyro3, Axl and Mer) family of receptor tyrosine kinases that
regulate multiple cellular responses including cell survival, proliferation, and migration. Axl …